Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$2.7B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.39B |
| 3 |
AbbVie
ABBV
|
+$1.95B |
| 4 |
Wells Fargo
WFC
|
+$1.03B |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$1.03B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Trip.com Group
TCOM
|
+$546M |
| 2 |
KRFT
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
|
+$274M |
| 3 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$273M |
| 4 |
Home Depot
HD
|
+$257M |
| 5 |
Progressive
PGR
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.23% |
| 2 | Healthcare | 10.87% |
| 3 | Financials | 9.03% |
| 4 | Technology | 8.57% |
| 5 | Consumer Discretionary | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5451
Lifecore Biomedical
LFCR
$244M
| $103K | ﹤0.01% |
7,093
-165,785
| -96% | -$2.39M |
2013 Q2
8 quarters
|
|
|
TST
5452
DELISTED
TheStreet, Inc.
TST
| $103K | ﹤0.01% |
5,702
+4,038
| +243% | +$74.8K |
2013 Q3
7 quarters
|
|
5453
DELISTED
ONCOLYTICS BIOTECH INC
ONCY
| $103K | ﹤0.01% |
206,787
-140,533
| -40% | -$95.5K |
2013 Q2
8 quarters
|
|
5454
DELISTED
BALTIC TRADING LIMITED COMMON STOCK
BALT
| $103K | ﹤0.01% |
64,253
-14,640
| -19% | -$22K |
2013 Q2
8 quarters
|
|
5455
ProShares Trust UltraShort Lehman 7-10 Year Treasury
PST
$11.1M
| $102K | ﹤0.01% |
4,198
+1,728
| +70% | +$41.5K |
2013 Q4
6 quarters
|
|
5456
DELISTED
Enservco Corp.
ENSV
| $102K | ﹤0.01% |
4,549
-5,463
| -55% | -$136K |
2014 Q2
4 quarters
|
|
5457
DELISTED
Goldfield Corporation
GV
| $102K | ﹤0.01% |
61,549
+23,809
| +63% | +$39K |
2014 Q3
3 quarters
|
|
|
ASFI
5458
DELISTED
Asta Funding Inc
ASFI
| $102K | ﹤0.01% |
12,206
-3,205
| -21% | -$26.6K |
2013 Q4
6 quarters
|
|
|
AKAO
5459
DELISTED
Achaogen Inc
AKAO
| $102K | ﹤0.01% |
16,917
-9,584
| -36% | -$59.4K |
2014 Q1
5 quarters
|
|
|
WREI
5460
DELISTED
Invesco Wilshire US REIT ETF
WREI
| $102K | ﹤0.01% |
2,413
-1,396
| -37% | -$62.9K |
2013 Q4
6 quarters
|
|
|
BKMU
5461
DELISTED
Bank Mutual Corp
BKMU
| $102K | ﹤0.01% |
13,294
-34,527
| -72% | -$252K |
2013 Q2
8 quarters
|
|
|
GAF
5462
DELISTED
SPDR S&P Emerging Middle East & Africa ETF
GAF
| $102K | ﹤0.01% |
1,537
-71
| -4% | -$4.91K |
2013 Q2
8 quarters
|
|
5463
Codexis
CDXS
$141M
| $101K | ﹤0.01% |
26,119
+22,698
| +663% | +$100K |
2013 Q2
8 quarters
|
|
5464
Ring Energy
REI
$341M
| $101K | ﹤0.01% |
9,037
+4,034
| +81% | +$47.5K |
2013 Q3
7 quarters
|
|
|
CRDS
5465
DELISTED
Crossroads Systems, Inc.
CRDS
| $101K | ﹤0.01% |
3,293
-1,358
| -29% | -$58.2K |
2013 Q4
6 quarters
|
|
|
RIVR
5466
DELISTED
RIVER VALLEY BANCORP
RIVR
| $101K | ﹤0.01% |
4,353
| – | – |
2013 Q4
6 quarters
|
|
|
PSAU
5467
DELISTED
Invesco Global Gold and Precious Metals ETF
PSAU
| $101K | ﹤0.01% |
6,663
-485
| -7% | -$8.06K |
2013 Q2
8 quarters
|
|
5468
Performance Shipping
PSHG
$20.3M
| – | – |
0
| – | – |
2013 Q2
8 quarters
|
|
5469
ProShares Ultra Technology
ROM
$1.29B
| $100K | ﹤0.01% |
21,008
-11,248
| -35% | -$56.8K |
2013 Q4
6 quarters
|
|
5470
Vericel Corp
VCEL
$2.1B
| $100K | ﹤0.01% |
27,938
-24,958
| -47% | -$85.5K |
2013 Q4
6 quarters
|
|
5471
Winmark
WINA
$1.13B
| $100K | ﹤0.01% |
1,014
-4,328
| -81% | -$402K |
2013 Q3
7 quarters
|
|
|
SVVC
5472
DELISTED
Firsthand Technology Value Fund, Inc. Common Stock
SVVC
| $100K | ﹤0.01% |
7,695
-3,240
| -30% | -$46.7K |
2013 Q2
8 quarters
|
|
|
AMRS
5473
DELISTED
Amyris Inc.
AMRS
| $100K | ﹤0.01% |
3,424
-48
| -1% | -$1.56K |
2013 Q2
8 quarters
|
|
|
OCAT
5474
DELISTED
OCATA THERAPEUTICS, INC. COMMON STOCK
OCAT
| $100K | ﹤0.01% |
18,803
-37,368
| -67% | -$239K |
2015 Q1
1 quarter
|
|
|
ALFA
5475
DELISTED
AlphaClone Alternative Alpha ETF
ALFA
| $100K | ﹤0.01% |
2,211
| – | – |
2014 Q1
5 quarters
|
|
Similar funds
Morgan Stanley's Q2 2015 Portfolio in Review
As of Q2 2015, Morgan Stanley held 7,065 positions worth $289B, up 6.3% from $272B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Morgan Stanley deployed $19B of net new capital in Q2 2015, opening 213 new positions and adding to 3,439 existing holdings. Its largest new stake was EQGP Holdings, LP: 2,862,984 shares worth $97.3M.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Trip.com Group, an estimated $546M trimmed.
- Morgan Stanley's largest Q2 2015 buy was EQGP Holdings, LP: 2,862,984 shares worth $97.3M.
- Morgan Stanley added most to Express Scripts Holding Company in Q2 2015, an estimated $2.7B increase.
- Morgan Stanley's biggest Q2 2015 reduction was Trip.com Group, cutting an estimated $546M.
- Morgan Stanley fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $162M.
- Morgan Stanley's ten largest holdings make up 12% of its $289B portfolio in Q2 2015.
- Morgan Stanley opened 213 new positions and closed 120 in Q2 2015.
- Morgan Stanley's portfolio value rose 6.3% quarter-over-quarter to $289B.
Based on Morgan Stanley's 13F filing for Q2 2015, filed 12 Aug 2015.